Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 61 - 70 of 238 results for "Pharmaceutical"

Short-seller knife twist for YouTube fundie

ELIZABETH MCARTHUR  |  FRIDAY, 9 AUG 2019
Activist short-seller Muddy Waters is shorting Burford Capital, YouTube fundie Neil Woodford's second largest holding in his embattled fund. Burford Capital is a lawsuit financier; Muddy Waters says it is taking a short position on Burford because ...

US bonds present ESG problem

ELIZABETH MCARTHUR  |  MONDAY, 15 JUL 2019
... data insights help us scrape the internet for websites that have been taken. We found some websites sponsored by pharmaceutical companies like ControlYourPain.com and other things which really aggressively marketed these drugs to physicians," Ground ...

Distribution reshapes globalisation: Capital Group

DARREN SNYDER  |  THURSDAY, 1 JUN 2017
Multi-national companies that happen to span the world's emerging markets have entered Version 3.0 when it comes to high-quality distribution models, reshaping the term globalisation. This is the view of Capital Group investment director Andy Budden ...

Countplus chair steps down after 11 years

ALEX BURKE  |  THURSDAY, 27 APR 2017
... are acting illegally by accessing full spectrum hemp/cannabis extract for a range of conditions where traditional Pharmaceutical drugs don't work well enough or have harmful side effects. This will remain a high priority," Lambert explained. As part ...

Arnhem SMA rating receives upgrade

JAMIE WILLIAMSON  |  THURSDAY, 2 MAR 2017
Lonsec's rating of Arnhem Investment Management's global separately managed account was upgraded in its latest round of reviews. Arnhem's global SMA, the Australia+ SMA, is now 'Recommended' by the ratings house, with Lonsec highlighting its "highly ...

Brandon Capital to build largest Commonwealth VC fund

JAMIE WILLIAMSON  |  WEDNESDAY, 14 DEC 2016
... gap that commonly occurs in the early stages of development, forcing the sale of medical discoveries to offshore pharmaceutical companies due to a lack of available investment capital in Australia. Brandon Capital managing director and principal executive ...

Low return world a boon for VC

JAMIE WILLIAMSON  |  THURSDAY, 20 OCT 2016
... holds significant potential for Australian investors, with funding from the likes of QIC and Hostplus driving major pharmaceutical developments. According to data released by the Australian Private Equity & Venture Capital Association (AVCAL) in April ...

Pharmaceuticals and tires top new Thomson Reuters diversity index

ALEX BURKE  |  TUESDAY, 27 SEP 2016
Roche Holding AG and the Michelin Group have topped Thomson Reuters' Diversity and Inclusion (D&I) index. The new index ranks the top 100 publicly-traded companies worldwide across 24 metrics to determine their diversity and inclusivity. The metrics ...

Myer Family Investments chair to retire

ALEX BURKE  |  MONDAY, 26 SEP 2016
... corporate memory required and considerable experience in the investment markets outside of the MFI Group." Australian Pharmaceutical Industries chief executive Stephen Roche will also join the board in October, taking over from Lloyd Jones, who is not ...

Food-related sector appetising for investors

JAMIE WILLIAMSON  |  THURSDAY, 22 SEP 2016
... has interest in Abundant Produce. "The commercial seed industry is dominated by a small number of transnational pharmaceutical corporations who have acquired or merged with competing firms. Since the commercialization of transgenic crops in the mid-1990s ...